Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
For those of you completely dismissing my question, what's your explanation for the price action?
Maybe investors are afraid that the company is going to come up with the $50 million by issuing 2.5 billion new shares, instead of getting funding from a major player?
I don't have a problem with people flipping the stock. Whatever skills people have, trading vs investing, we're all here to make money. But no one gives a rat's ass, or necessarily believes, when someone makes a claim that they bought for X and sold for Y. It's sad really, when an anonymous poster tries to get validation for his supposed prowess by making such claims on a message board. And then to top it off say that people are jealous of them. Sure, you're the greatest trader ever!!! Feel better now?
I sold all my shares at the very top yesterday, and bought them all back at the very bottom today. Believe me, I wouldn't lie to you.
Your question wasn't directed at me, but I swapped some of my common shares for the preferreds a few weeks ago. My thinking was that Koos owns mostly (if not all) preferreds, so whatever kind of deals happen down the road, you can be sure the preferreds will benefit at least as much as the commons, and likely more.
They could put out a PR after the 15th, something like, "Based on BRG's review, which values our company at many multiples of our current share price, we have begun discussions with several potential buyers". I wouldn't want to be without shares when that comes out!
I pointed out during the last mini run a few days ago that the preferreds weren't keeping up the common stock. I wasn't sure if that was significant but since Koos owns mostly the preferreds, I would think the two stocks would move together at the start of a real run. The preferreds are actually down slightly at the moment, so it will be interesting to see how this run in the common shares ends the day.
I wonder if anything can be read into the fact that the preferreds are not up as much as the common stock? I think most of Koos's money is in the preferreds, and if buyout rumors were true I would think the preferreds would be keeping pace, if not leading the charge.
The problem with this kind of long slide is that you have trapped longs at higher levels, who will be grateful to recoup some or all of their losses and will be selling into any upturn. It makes it that much tougher to achieve higher prices. It's going to take blockbuster news for us to even get back to where we were months ago.
Need to get this stupid song out of my head.
When the stock dropped below .016, this lyric from the "Wreck of the Edmund Fitzgerald" popped into my head:
At seven PM, a main hatchway caved in, he said
"Fellas, it's been good to know ya"
C'mon, let's see some buying!!
My last post today.
Go to the message board on any OTC stock that you KNOW is not legit, and you see the same posts you see here ie. I know what I own, this is the OTC, if you don't like it then sell, these things take time, etc. And those sentiments aren't necessarily wrong but sometimes the stock really is worthless.
My investment thesis here has been than the patents have potential and Koos would not have spent the time, effort and money to become current if he didn't think he owned something valuable.
But price is truth and we can't deny the current price or the recent price action. At some point I would think the price would get so low that it would be impossible for a big player to pass on, and the risk/reward too compelling, IF we really owned something of value.
I thought becoming pink current would boost the share price. It didn't. I though clearing the convertible notes would boost the share price. It didn't. I thought engaging BRG as a first step to monetizing the IP would boost the share price. It didn't.
Despite some of the insane price targets posted here, and articles from many years ago, the Market is saying (potential notwithstanding) that this stock is worth less than 1.7 cents, and becoming worth less every day.
Why?
Am I the only one starting to think something's not right here? Yeah yeah I know all about the need for patience, and MM manipulation, but at some point you need to consider less benign explanations.
They ultimately want a low price for sure. But rather than keep the price pinned at say 2 cents, why don't the MMs buy until the price gets to 3 cents, and then short back down to 2 cents, rinse and repeat. Wouldn't they make more money that way, and still keep the price low?
LOL I need another cup of coffee before answering. Convertible note holders? But I thought they were gone. So who else would be benefiting from keeping the price from fluctuating, and given that MMs have their own interests to look after why wouldn't they still want the price to move up as well as down?
Thanks. I too am afraid to close my position because of the potential value of the patents. And that potential is why I'm heavily invested. But I've had some OTC stocks in the past that had great runs with far less going for them. And I would think the MMs could make a lot more money for themselves by letting the stock run up and down rather than keeping it pinned at this low price. So I'm not sure I buy into the theory that it is the MMs keeping the price from going up. In any event, hopefully we find out more soon after the analysis is completed on November 15.
And yet the disconnect exists between posters on this board who believe the stock could be worth dollars, and the investing public at large who don't even think it's worth 2 cents. Why? Are we the only ones who understand the potential of the technology? Other investors don't think the risk/reward at this price is worth it? It doesn't make sense.
FWIW, I disagree with your assertion that Koos did something stupid. In fact, he did right by shareholders by communicating his accomplishments and plans going forward. It's not his fault that investors got ahead of themselves, or believed some of the ridiculous estimates of multi-dollar price targets by year end. I am disappointed and somewhat concerned by the price action, but Koos is and should be looking long term, not trying to boost the share price for the benefit of flippers.
I'd like to think so, but am starting to have some doubts. At this price, the risk/reward is almost uncalculable (2 cent maximum loss versus how much possible gain?) and yet buyers are not stepping up. Hard to understand why not.
The Wall Street expression "Price is truth" seems to apply here. We can blame the evil MMs, or investors don't understand our great line up of patents, or buyers not slapping the ask, or all the other excuses the bulls are making for our price performance. But the collective wisdom of the Market is saying our company is only worth 2 cents a share, no matter how underpriced we may think it is.
Please, don't bring logic and reason onto this board!!!!
That what nags at me. Everything we know about the company is public knowledge, the technology, patents, etc. The articles that get posted here from 2019, 2016, etc. are not news. The options Koos has whether to sell the company, or make licensing deals, or whatever have been considered as well. But apparently only those of us on this board have any confidence the price has big upside potential. It's puzzling.
I don't put big pharma on a pedestal, in fact, just the opposite. I just wonder given Koos is operating independently, or at least with few affiliations, and yet seems to have almost cornered the market on these valuable patents. Seeing that the stock is trading where it is, investors have similar questions. Hopefully we find out soon why Koos spent the time and money to get current.
Does the granting of a patent say anything about the potential of that application, or does the patent office see that nothing similar has been patented previously so they just grant the application? How can patent office employees have enough expertise in every field to do a deep analysis of every application? Wouldn't big pharma have the money and expertise to be trying to patent everything they could around this technology? How is it that Koos is scooping them on these? Serious questions.
I respectfully disagree with you. I am very disappointed in the reaction to the news release, but I think it is due to the fact that a buyout was overhyped. The 8k spelled out some significant milestones and if he hadn't put that out then investors may have complained that he wasn't communicating enough! My take on all of this is Koos spent a lot of time and money getting current and cleaning up the convertible debt, and I don't see that as anything but positive. Hopefully the next news release will tell us why, and the price will move up accordingly.
That would be nice. 10 down days in a row is quite enough!
At least with a falling knife there's a chance you could catch the shaft rather than the blade. Today will be the ninth down day in a row. I guess in a way we are getting the shaft!
Doesn't seem like good news, if you're right.
So if I'm telling you a 20/50 cross on a monthly chart isn't useful, I'm day trading? I'm long this stock, but the amount of disinformation being spewed by posters here would be funny if not so pathetic. Good luck to everyone. The bashers are pretty transparent, the pumpers are a little more subtle.
A 20/50 cross on a monthly chart is way too delayed a signal to be meaningful. Even on a weekly chart 9/20 is more commonly used. Of more significance is that a red day today will be 8 in a row, and there has been no real try at a rally so far.
You're the last of the Mohicans! LOL Where are all the posters with their price predictions in the multi-dollars?
Whatever. I hope we all make boatloads of money.
I agree about the potential which is why I'm heavily invested here. The recent price action has been disappointing, which I think we can all agree with.
No offense taken, but see my last post.
Not the first time in the OTC. And not the first time to see justifications like "this is how OTC stocks behave", or "you need to be patient", or "if you don't like it then sell and move on". My only point was that I would have thought the price would behave better given what I thought was a very positive news release from Koos, and that big pharma (the true experts) might recognize the value of our patents.
I think his question is valid. I too am a shareholder and holding my shares because of the potential. But the share price should be reflecting everything known about the stock, including the potential we think it has. Including all the press releases posted here repeatedly from months and years ago. Do you think the posters here at IHUB are more knowledgeable than everyone else? Sure we can't expect a huge run without significant news, but a 40% drop in value in just over a week is certainly not something I was expecting either.
I would gladly trade in these "golden opportunities" for some price appreciation!
You're talking fundamentals. I'm guessing 99% of OTC investors are looking where they can make the quickest buck, and once they determine their current investment will not give them immediate riches, they move on.
We need a catalyst. The recent 8k was very positive, but investors were hoping for some blockbuster news (buyout or new licensing deal, etc.) Without anything of that nature imminent, the short term money is going elsewhere.
Generally, does a patent being granted infer anything about the value or viability of that patent? Playing devil's advocate, could Koos just be trying to patent anything not yet patented regarding this technology in hopes that one of them turns out to be valuable?